Conducting clinical research studies with
Call to participate

Posts Tagged ‘ Alzheimer’s study ’

Alzheimer’s Study

Wednesday, November 25th, 2015


Alzheimer’s is a progressive disease of the brain. Brian cells die over a period of several years, and symptoms progress from mild to severe.  Alzheimer’s is one of the leading causes of death in the U.S., and affects over 5 million Americans.

It has been over a decade since the FDA has approved any new medications for the treatment of Alzheimer’s.  Clinical research is currently underway in New London at CCRstudies, testing an investigational add-on medication. The team of investigators includes Laurence Radin, MD, Edward McDermott, Jr., MD, and Andrea Stewart, APRN.   This medication is taken in conjunction with the study patients current dosage of Aricept (Donepezil.)  The investigational medication is designed to improve thinking, memory, reasoning and cognition.  It is the Phase 3 of the clinical trial process.

Those interested in learning more about the Alzheimer’s study underway in New London can contact a member of the CCRstudies team at (860)443-4567, or click on this link for further details

In addition to the study patient, caregivers play an important role in this trial.  There is no cost to participate and compensation is available for time and travel to the study patient and caregiver.

Alzheimer’s Research

Monday, August 25th, 2014

Geras Study Flyer

Have You or a Loved One Received Care for Memory Impairment?

A Study for Patients with Mild Cognitive Impairment or Mild Dementia due to Alzheimer’s Disease

A research study is being conducted to gather information about caring for patients diagnosed with Mild Cognitive Impairment or Mild Dementia due to Alzheimer’s Disease.

Patients may qualify for the study if they:

  • Are between 55 and 85 years old
  • Have a reliable family member or friend willing to serve as a study partner and attend all study visits

If you choose to participate in this study, you will help us to collect information that may help others affected by Alzheimer’s disease in the future.

Study Team: Dr. Laurence Radin, Andrea Stewart APRN, Diane Palmer RN

Call (860)443-4567 to learn more or email